Related Experiment Video
Updated: Jan 12, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Liposomal Cancer Drug Database (LCDD): a comprehensive resource for liposome research in cancer therapy and diagnosis
Marziyeh Mousazadeh1, Babak Khorsand2, Sayed Mostafa Modarres Mousavi1
1Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Jalal Al Ahmad Highway, Tehran, 14115-154, Iran.
Abstract:
The Liposomal Cancer Drug Database (LCDD) is a comprehensive web-based resource that provides an extensive overview of liposome-based formulations used in cancer therapy and diagnostics. LCDD compiles data from about 4500 research articles, categorizing information into 14 key attributes for each research article such as type of cancer, liposome size, type of experiments, cell line type, in vivo animals, liposome function, and type of cargo. The database is built on direct literature investigations and serves as a critical tool for researchers developing liposome-based cancer therapeutic drugs, diagnostic platforms, or theragnostic solutions. LCDD is available for noncommercial purposes as a free database at https://bioinformaticscollege.ir/lcdd/.

